HCRU and costs among patients with schizophrenia switching from oral risperidone/paliperidone to once-monthly paliperidone palmitate: A VHA claims analysis

by | Apr 14, 2020 | Mental Health, Neurological, Publication

Abstract Authors: Charmi Patel, Antoine El Khoury, Ahong Huang, Li Wang, Richa Bashyal Background: Schizophrenia is associated with high health care resource utilization and treatment costs. Objective: This study compared treatment patterns, health care resource...